BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Osseon Therapeutics, Inc. Announces Another VCF Product


6/14/2013 9:47:04 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SANTA ROSA, Calif., June 14, 2013 /PRNewswire/ -- Osseon® announces the release of the Osseoflex® CD-H hydraulic cement delivery system. This latest addition to the Osseon product line is designed for delivery of medium to high viscosity bone cement during the treatment of vertebral compression fractures (VCF). The Osseoflex® CD-H hydraulic cement delivery system complements Osseon's family of steerable vertebral augmentation devices.

The Osseoflex® CD-H hydraulic cement delivery system is an improvement on other bone cement delivery systems, enabling precise, controlled delivery of bone cement when filling a cavity in a vertebra.

Osseon is also offering for those physicians who prefer a higher viscosity cement, a new, more viscous PMMA bone cement, which provides double the working time of lower viscosity cements.

The first vertebral augmentation cases have been performed with Osseon's new Osseoflex® CD-H hydraulic cement delivery system by Paul Fuchs, MD of Orthopedic Specialists of SW Florida in Fort Meyers, FL, and Chad Hartley, MD of Panacea Brain & Spine in Lake Havasu City, AZ.

Osseon continues to develop innovative products which address both physician and patient needs for the treatment of vertebral compression fractures.

About Osseon:
Osseon® Therapeutics, Inc., headquartered in Santa Rosa, CA, is dedicated to developing and commercializing state of the art medical devices for minimally invasive treatments for degenerative bone and joint disease, including the treatment of vertebral compression fractures. The company's patented, steerable delivery system offers more treatment options than other commercial solutions as well as offering significant advantages in procedural efficiency and cost. By improving the treatment of compression fractures within the lower portion of the thoracic and the entire lumbar vertebral spine, Osseon offers new, forward thinking solutions to patients suffering from these maladies, as well as to the physicians and medical facilities that treat them. Osseon's products are distributed globally.

For more information, visit our website at osseon.com.

Osseon® is a registered trademark of Osseon Therapeutics, Inc. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

 

SOURCE Osseon Therapeutics, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES